Showing results (2201-2210 of 3,030) with videos related to

Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|March 6, 2026
Beehive Products: A Review on their Nutritional and Therapeutic PotentialElia Ranzato, Gregorio Bonsignore, Alessia Garau, et al.
Current Pharmaceutical Biotechnology|April 30, 2026
Hydroxysafflor Yellow A Attenuates Myocardial Ischemia/Reperfusion Injury-induced Platelet Activation: Role of Mitochondrial Function and AutophagyYaqi Zhang, Zhihui Wang, Ruotong Li, et al.
Current Pharmaceutical Biotechnology|April 5, 2026
The Mpox Outbreak 2025: A Call for Coordinated Global Action and EquitySachin Yadav, Shivangi, Yashika, et al.
Current Pharmaceutical Biotechnology|May 15, 2026
CRISPR-Cas Systems and CHO in Biopharmaceuticals: Unlocking New Possibilities in Gene EditingSoofia Sorourian, Abbas Behzad Behbahani
Current Pharmaceutical Biotechnology|May 15, 2026
Nanozymes in Personalized Medicine: A Review of the Potential for Tailored Diagnostic and Therapeutic ApplicationsMaryam Kainat, Irfan Ahmad, Afsana Huseynova Anvar, et al.
Current Pharmaceutical Biotechnology|May 21, 2026
Immunomodulatory Roles of Probiotics: From Intestinal Barrier Regulation to Clinical ApplicationsGaurav Kant Sarogi, Anurag Agrawal, Mamta Kumari, et al.
Current Pharmaceutical Biotechnology|December 9, 2020
Is Hospital Autopsy Auditing Suitable for Clinical Risk Manage ment? Actualities and Perspectives of Auditing in the Autopsy Room Following Italian Law 24/2017 on Patient SafetyMartina Zanon, Eleonora Valentinuz, Martina Montanaro, et al.
Current Pharmaceutical Biotechnology|June 2, 2026
Mechanisms of Glia and Non-coding RNAs in Traumatic Brain Injury: Insights and Intervention StrategiesShiyu Miao, Ruoyu Li, Zhaoyang Zhang, et al.
Current Pharmaceutical Biotechnology|June 9, 2026
Adiponectin Mediates FGF21 to Alleviate Sepsis-induced Acute Lung Injury by Ameliorating Fibrosis and Inhibiting Oxidative StressFanghua Gong, Shangwen Wang, Xuehui Liu, et al.
Current Pharmaceutical Biotechnology|June 8, 2026
Interleukin-22 Promotes Lung Adenocarcinoma (LUAD) Progression Through Activation of the PI3K/AKT Signaling PathwayQingyu Meng, Yadong Li, Yanhu Liu, et al.
Pageof 303